Does the Application of Cold Decreases the Pain Associated in the Pose of a Patch of Capsaicine at High Concentration on the Carrier Patients of Localized Neuropathic Pains ? - DIDOCAP
DIDOCAP
1 other identifier
interventional
100
1 country
3
Brief Summary
Nursing study, prospective, randomized, two-center open-label. Patients will be randomized into two groups during their first laying Qutenza®:
- Patients receiving the laying of Qutenza® without refrigerated cushion
- Patients receiving the laying of Qutenza® associated with a refrigerated cushion The objective of the study is to evaluate the effectiveness of the application of cold to the reduction of pain (burning) after one hour of patch installation high concentration capsaicin (Qutenza®) in patients localized neuropathic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2016
CompletedFirst Posted
Study publicly available on registry
August 17, 2016
CompletedStudy Start
First participant enrolled
March 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2020
CompletedResults Posted
Study results publicly available
August 15, 2024
CompletedDecember 3, 2025
November 1, 2025
3.8 years
August 12, 2016
June 15, 2023
November 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analogue Pain Scale (Burning Pain)
Burning pain will be estimated by the patient using a non-graduated 10 cm line, presented horizontally to the patient with the extreme position of the vertical border on the left (0mm) representing the absence of perceived pain and the extreme position on the right (10 cm), the perception of the maximum pain that the patient can imagine. The information obtained is measured and translated into a score between 0 and 10. The patient will be asked: "How would you rate the intensity of pain caused by Qutenza patch application?
after 1 hour of installation of Qutenza patch
Study Arms (2)
Qutenza® without refrigerated cushion
NO INTERVENTIONQutenza® without refrigerated cushion
Qutenza® with refrigerated cushion
EXPERIMENTALQutenza® with refrigerated cushion
Interventions
Eligibility Criteria
You may qualify if:
- Major
- Do not opposing the participation in the study
- Monitoring in the case of localized neuropathic pain
- Diagnostic with neuropathic pain score ≥ 4
- Neuropathic pain conventional treatment failure of first-line
- Front advantage of laying a first patch Qutenza®
- With ability to understand the proposed study
You may not qualify if:
- Patch Installation on the feet, face, mucous membranes
- Eutectic mixture of local anesthetics (EMLA) Pose premedication
- Having Already received prior to the installation of a patch of Qutenza®
- Allergy to components Qutenza®
- Known and poorly stabilized hypertension
- Known cryoglobulinaemia
- Pregnant or lactating women
- Patient enjoying a measure of legal protection (guardianship, guardianship ...)
- Private Patient freedom
- No affiliation to a social security scheme.
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
CHLVO de Challans
Challans, 85300, France
CHD Vendée de la Roche sur Yon
La Roche-sur-Yon, 85925, France
Clinique Brétéché
Nantes, 44000, France
Related Publications (1)
Tailliez N, Planche L, Dorion A, Kacki N, Dimet J, Pluchon YM. Effect of Cooling Capsaicin Application Site on Reducing Burning Sensation in Neuropathic Pain Patients: A Randomized Controlled Trial. Pain Manag Nurs. 2025 Apr;26(2):e159-e164. doi: 10.1016/j.pmn.2024.09.001. Epub 2024 Nov 12.
PMID: 39532578RESULT
Results Point of Contact
- Title
- Dr Yves-Marie PLUCHON
- Organization
- Centre Hospitalier Départemental Vendée
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2016
First Posted
August 17, 2016
Study Start
March 2, 2017
Primary Completion
December 4, 2020
Study Completion
December 4, 2020
Last Updated
December 3, 2025
Results First Posted
August 15, 2024
Record last verified: 2025-11